Featured Blog
-
December 09, 2024
By MedStar Health Research Institute
This article was written by D. Max Smith, PharmD, BCPS. New pharmacogenetic research answers questions about genetics and dosing of the breast cancer drug ribociclib and opens more discus...
Browse blogs by hospital
Share this
All Blogs
-
January 07, 2018
By MedStar Health Research Institute
Christina (Tina) Stanger, MA, CRA, Director of MHRI’s Office of Contract and Grant Management, was recognized as the fourth quarter 2017 SPIRIT of Excellence Award recipient. The award was presented b...
-
January 07, 2018
By MedStar Health Research Institute
The Revised Common Rule compliance date is quickly approaching on January 19, 2018. The Office of Research Integrity and MHRI leadership are working to ensure required changes to our policies and proc...
-
January 07, 2018
By MedStar Health Research Institute
Recently published research at MedStar investigated the link between the educational level of study participants and treatment preferences for type 2 diabetes medication. This stratification study sou...
-
January 07, 2018
By MedStar Health Research Institute
An analysis of the effect of diet on postmenopausal women as part of the Women’s Health Initiative shows that reducing fats and increasing vegetable, fruit, and grain intake can reduce the risk of nee...
-
January 07, 2018
By MedStar Health Research Institute
In December, MHRI associates took some time out of their busy schedules to celebrate the successes of 2017 with their fellow associates. These events are also our opportunity to recognize associ...
-
December 14, 2017
In the 1990s, the Food and Drug Administration (FDA) approved a treatment for bladder cancer called Bacillus Calmette-Guerin therapy, or BCG, which stimulates the immune system and helps keep patients...